E S Johnson, L G Smith. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAgedBacterial Infections/drug therapyBacterial Infections/microbiologyCefotaxime/adverse effectsCefotaxime/analogs & derivativesCefotaxime/therapeutic useCeftizoximeCross Infection/drug therapyEndocarditis, Bacterial/drug therapyFemaleHumansMaleMiddle AgedPneumonia/drug therapyPyelonephritis/drug therapySepsis/drug therapyUrinary Tract Infections/drug therapy
Substances: See more » CeftizoximeCefotaxime
Year: 1982 PMID: 6296000 DOI: 10.1093/jac/10.suppl_c.151
Source DB: PubMed Journal: J Antimicrob Chemother ISSN: 0305-7453 Impact factor: 5.790